iShares Genomics Immunology and Healthcare ETF (IDNA)
NYSEARCA: IDNA · Real-Time Price · USD
28.79
+0.11 (0.38%)
Jun 3, 2026, 12:55 PM EDT - Market open
IDNA Holdings Information
IDNA is an equity ETF with a total of 64 individual holdings. The top holdings are Revolution Medicines stock at 7.83%, Moderna at 6.34%, Ipsen at 4.73%, Twist Bioscience at 4.42%, and Merck & Co. at 4.40%.
Total Holdings
64
Top 10 Percentage
48.04%
Asset Class
Equity
ETF Category
Health
Assets
163.14M
PE Ratio
16.27
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | 7.83% |
| 2 | MRNA | Moderna, Inc. | 6.34% |
| 3 | EPA: IPN | Ipsen S.A. | 4.73% |
| 4 | TWST | Twist Bioscience Corporation | 4.42% |
| 5 | MRK | Merck & Co., Inc. | 4.40% |
| 6 | EXEL | Exelixis, Inc. | 4.32% |
| 7 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 4.10% |
| 8 | ETR: BAYN | Bayer Aktiengesellschaft | 4.01% |
| 9 | SWX: ROP | Roche Holding AG | 3.97% |
| 10 | LON: GSK | GSK plc | 3.92% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 3.67% |
| 12 | BNTX | BioNTech SE | 3.63% |
| 13 | INCY | Incyte Corporation | 3.55% |
| 14 | EPA: SAN | Sanofi | 3.32% |
| 15 | REGN | Regeneron Pharmaceuticals, Inc. | 3.19% |
| 16 | CPH: GMAB | Genmab A/S | 3.06% |
| 17 | IDYA | IDEAYA Biosciences, Inc. | 2.71% |
| 18 | IBRX | ImmunityBio, Inc. | 2.68% |
| 19 | RCUS | Arcus Biosciences, Inc. | 2.15% |
| 20 | CAI | Caris Life Sciences, Inc. | 2.12% |
| 21 | TYO: 4528 | Ono Pharmaceutical Co., Ltd. | 1.95% |
| 22 | CRSP | CRISPR Therapeutics AG | 1.88% |
| 23 | NVAX | Novavax, Inc. | 1.74% |
| 24 | ABCL | AbCellera Biologics Inc. | 1.67% |
| 25 | IOVA | Iovance Biotherapeutics, Inc. | 1.47% |
As of Jun 1, 2026